Incretin mimetics are particularly suitable for: Patients where weight loss would provide additional health benefits Individuals at high cardiovascular risk who may benefit from the cardioprotective effects of certain agents (liraglutide, semaglutide, dulaglutide) Patients wishing to avoid or delay insulin therapy Those requiring substantial HbA1c reductions to reach target levels NICE NG28 specifies continuation criteria for GLP-1 receptor agonists in triple therapy: continue only if there is a beneficial metabolic response, defined as a reduction of at least 11 mmol/mol (1.0%) in HbA1c and weight loss of at least 3% of initial body weight at six months
Substances that raise GSH levels are being used with increasing frequency in the field of toxicology with considerable success
The top six highest recommended anti-aging treatments in 2020 include CoolSculpting, micro-needling with SkinPen, dermal fillers, laser skin resurfacing with ActiveFX, Kybella, and Thermage
Patients with diabetes should also monitor blood glucose, as dehydration and illness can affect glycemic control
If you're a practitioner looking to treat these concerns safely and effectively, enroll in our Ozempic Face Treatment Course